HUM vs PRLD
Humana Inc (HUM) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the HUM and PRLD stock pages for the full models.
Not investment advice.